Viva Biotech Holdings (HKG:1873)
Hong Kong
· Delayed Price · Currency is HKD 1.670
-0.040 (-2.34%)
Apr 29, 2026, 4:08 PM HKT
Viva Biotech Holdings Employees
Viva Biotech Holdings had 2,169 employees as of December 31, 2025. The number of employees increased by 106 or 5.14% compared to the previous year.
Employees
2,169
Change (1Y)
106
Growth (1Y)
5.14%
Revenue / Employee
887.30K HKD
Profits / Employee
112.75K HKD
Market Cap
3.53B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Antengene Corporation | 129 |
| Mirxes Holding Company | 347 |
| BioDlink International Company | 613 |
| TYK Medicines | 173 |
| Clover Biopharmaceuticals | 243 |
| Qyuns Therapeutics | 337 |
| Shandong Boan Biotechnology | 714 |
| Jiangsu Recbio Technology | 491 |
Viva Biotech Holdings News
- 4 weeks ago - Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up - PRNewsWire
- 6 weeks ago - Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA - PRNewsWire
- 4 months ago - Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities - PRNewsWire
- 4 months ago - Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion. - PRNewsWire
- 7 months ago - Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry - PRNewsWire
- 8 months ago - Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights - PRNewsWire
- 8 months ago - Viva Biotech Announces Its 2025 Interim Results: CRO Revenue Returned to Positive Growth, New CDMO Commercialization Projects Showed Promising Growth - PRNewsWire
- 1 year ago - Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection - PRNewsWire